Among 169 breast cancer tissues, ER+ and PR+ were observed in 60.4% (n = 102) and 53.3% (n = 90) samples, respectively, and HR+ was found in 63.3% (n = 107) samples. This evidence concerns the gene ESR1 and breast cancer.